
GSK Backs Vesalius: A New Era for Parkinson’s Therapy
In the dynamic realm of pharmaceutical research and development, the pursuit of innovative solutions for complex diseases remains unyielding. A recent and noteworthy advancement in this field is the $80 million investment by GlaxoSmithKline (GSK) […]